Chueh‐Chuan Yen

3.5k total citations · 1 hit paper
57 papers, 2.3k citations indexed

About

Chueh‐Chuan Yen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Chueh‐Chuan Yen has authored 57 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Chueh‐Chuan Yen's work include Colorectal Cancer Treatments and Studies (11 papers), Sarcoma Diagnosis and Treatment (8 papers) and Gastric Cancer Management and Outcomes (6 papers). Chueh‐Chuan Yen is often cited by papers focused on Colorectal Cancer Treatments and Studies (11 papers), Sarcoma Diagnosis and Treatment (8 papers) and Gastric Cancer Management and Outcomes (6 papers). Chueh‐Chuan Yen collaborates with scholars based in Taiwan, United States and Japan. Chueh‐Chuan Yen's co-authors include Po‐Min Chen, Tzeon-Jye Chiou, Wei-Shu Wang, Liu H, Muh‐Hwa Yang, Masanobu Takahashi, Ioannis Xynos, Yuichiro� Doki, Chih‐Hung Hsu and Sung‐Bae Kim and has published in prestigious journals such as Journal of Clinical Oncology, Bioinformatics and PLoS ONE.

In The Last Decade

Chueh‐Chuan Yen

56 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial

2019 751 citations Chueh‐Chuan Yen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chueh‐Chuan Yen Taiwan	23	1.2k	821	708	541	204	57	2.3k
M.E.L. van der Burg Netherlands	27	961 0.8×	664 0.8×	417 0.6×	452 0.8×	383 1.9×	69	2.4k
Tsuyoshi Hayashi Japan	24	1.1k 1.0×	938 1.1×	872 1.2×	536 1.0×	267 1.3×	134	2.2k
Kenneth Webster United States	30	769 0.7×	845 1.0×	481 0.7×	452 0.8×	284 1.4×	76	3.1k
J. J. Kavanagh United States	32	879 0.8×	754 0.9×	360 0.5×	859 1.6×	216 1.1×	95	3.0k
G. Veerman Netherlands	20	1.1k 1.0×	347 0.4×	730 1.0×	635 1.2×	184 0.9×	52	1.9k
Yasunori Emi Japan	28	906 0.8×	694 0.8×	917 1.3×	546 1.0×	138 0.7×	116	2.2k
David Chu United States	27	1.1k 0.9×	319 0.4×	674 1.0×	1.1k 2.0×	171 0.8×	56	2.8k
Paolo Bidoli Italy	27	2.0k 1.7×	365 0.4×	1.9k 2.7×	531 1.0×	137 0.7×	127	3.1k
Jin S. Lee United States	30	1.2k 1.0×	472 0.6×	960 1.4×	1.3k 2.5×	343 1.7×	60	3.4k
M. Homerin France	10	2.9k 2.5×	884 1.1×	883 1.2×	389 0.7×	423 2.1×	17	3.5k

Countries citing papers authored by Chueh‐Chuan Yen

Since Specialization

Citations

This map shows the geographic impact of Chueh‐Chuan Yen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chueh‐Chuan Yen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chueh‐Chuan Yen more than expected).

Fields of papers citing papers by Chueh‐Chuan Yen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chueh‐Chuan Yen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chueh‐Chuan Yen. The network helps show where Chueh‐Chuan Yen may publish in the future.

Co-authorship network of co-authors of Chueh‐Chuan Yen

This figure shows the co-authorship network connecting the top 25 collaborators of Chueh‐Chuan Yen. A scholar is included among the top collaborators of Chueh‐Chuan Yen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chueh‐Chuan Yen. Chueh‐Chuan Yen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hsu, Po‐Kuei, Chien‐Sheng Huang, Yi‐Chen Yeh, et al.. (2021). Treatment Patterns and Outcomes in Patients with Esophageal Cancer: An Analysis of a Multidisciplinary Tumor Board Database. Annals of Surgical Oncology. 29(1). 572–585. 9 indexed citations

Lee, Chih‐Ying, Chueh‐Chuan Yen, Hsiu‐Ju Yen, et al.. (2016). Outcomes of 50 Patients With Ewing Sarcoma Family of Tumors Treated at a Single Institution in Taiwan. Medicine. 95(22). e3830–e3830. 11 indexed citations

Yen, Chueh‐Chuan, Wei‐Ming Chen, Chun‐Yu Liu, et al.. (2016). Cytotoxic mechanism of PLK1 inhibitor GSK461364 against osteosarcoma: Mitotic arrest, apoptosis, cellular senescence, and synergistic effect with paclitaxel. International Journal of Oncology. 48(3). 1187–1194. 38 indexed citations

Lee, Yu‐Ting, Chia‐Jen Liu, Yu‐Wen Hu, et al.. (2015). Incidence of Second Primary Malignancies Following Colorectal Cancer. Medicine. 94(26). e1079–e1079. 27 indexed citations

Wang, Hsei-Wei, Shung-Haur Yang, Jen-Kou Lin, et al.. (2014). Temsirolimus enhances the efficacy of cetuximab in colon cancer through a CIP2A-dependent mechanism. Journal of Cancer Research and Clinical Oncology. 140(4). 561–571. 21 indexed citations

Chang, Hui Hua, et al.. (2014). MTOR inhibition enhances NVP-AUY922-induced autophagy-mediated KIT degradation and cytotoxicity in imatinib-resistant gastrointestinal stromal tumors. Oncotarget. 5(22). 11723–11736. 22 indexed citations

Lin, Chih‐Lung, Nai‐Jung Chiang, Chueh‐Chuan Yen, et al.. (2013). Selecting Tyrosine Kinase Inhibitors for Gastrointestinal Stromal Tumor with Secondary KIT Activation-Loop Domain Mutations. PLoS ONE. 8(6). e65762–e65762. 17 indexed citations

Yeh, Chi‐Tai, Alexander T.H. Wu, Peter Mu‐Hsin Chang, et al.. (2012). Trifluoperazine, an Antipsychotic Agent, Inhibits Cancer Stem Cell Growth and Overcomes Drug Resistance of Lung Cancer. American Journal of Respiratory and Critical Care Medicine. 186(11). 1180–1188. 170 indexed citations

Lin, Jen-Kou, Wei-Shone Chen, Tzu-Chen Lin, et al.. (2012). Concurrent Chemoradiotherapy Followed by Metastasectomy Converts to Survival Benefit in Stage IV Rectum Cancer. Journal of Gastrointestinal Surgery. 16(10). 1888–1896. 13 indexed citations

10.

Lin, Jen-Kou, Wei-Shone Chen, Tzu-Chen Lin, et al.. (2011). A new classification scheme for recurrent or metastatic colon cancer after liver metastasectomy. Journal of the Chinese Medical Association. 74(11). 493–499. 9 indexed citations

11.

H, Liu, et al.. (2010). A Novel E1B-55kD-Deleted Oncolytic Adenovirus Carrying Mutant KRAS-Regulated hdm2 Transgene Exerts Specific Antitumor Efficacy on Colorectal Cancer Cells. Molecular Cancer Therapeutics. 9(2). 450–460. 4 indexed citations

12.

Hsiao, Liang-Tsai, Tzeon-Jye Chiou, Liu H, et al.. (2006). Extended Lamivudine Therapy against Hepatitis B Virus Infection in Hematopoietic Stem Cell Transplant Recipients. Biology of Blood and Marrow Transplantation. 12(1). 84–94. 35 indexed citations

13.

Chen, Po‐Min, Chueh‐Chuan Yen, Muh‐Hwa Yang, et al.. (2006). High Prevalence of SV40 Infection in Patients with Nodal Non-Hodgkin's Lymphoma But Not Acute Leukemia Independent of Contaminated Polio Vaccines in Taiwan. Cancer Investigation. 24(3). 223–228. 8 indexed citations

14.

Wang, Wei-Shu, Jen-Kou Lin, Tzeon-Jye Chiou, et al.. (2004). EIA versus RIA in detecting carcinoembryonic antigen level of patients with metastatic colorectal cancer.. PubMed. 51(55). 136–41. 9 indexed citations

15.

Bai, Li‐Yuan, Muh‐Hwa Yang, Tzeon‐Jye Chiou, et al.. (2003). Non‐Hodgkin lymphoma in elderly patients. Cancer. 98(6). 1188–1195. 5 indexed citations

16.

Wang, Wei-Shu, et al.. (2003). All-trans retinoid acid increases Notch1 transcript expression in acute promyelocytic leukemia. Advances in Therapy. 20(6). 337–343. 6 indexed citations

17.

Chao, Ta‐Chung, Wei-Shu Wang, Chueh‐Chuan Yen, et al.. (2003). A Dose-Escalating Pilot Study of Sterically Stabilized, Pegylated Liposomal Doxorubicin (Lipo-Dox®) in Patients with Metastatic Breast Cancer. Cancer Investigation. 21(6). 837–847. 28 indexed citations

18.

Wang, Wei-Shu, Jen-Kou Lin, Tzeon-Jye Chiou, et al.. (2002). Tumor marker CEA in monitoring of response to tegafur-uracil and folinic acid in patients with metastatic colorectal cancer.. PubMed. 49(44). 388–92. 15 indexed citations

19.

Chen, Po‐Min, Muh‐Hwa Yang, Yu‐Chen Lin, et al.. (2002). Detection of reactivation and genetic mutations of the hepatitis B virus in patients with chronic hepatitis B infections receiving hematopoietic stem cell transplantation1. Transplantation. 74(2). 182–188. 22 indexed citations

20.

Chiou, Tzeon-Jye, Shiao-Lin Tung, Wei-Shu Wang, et al.. (2002). Pulmonary Function Changes in Long-Term Survivors of Chronic Myelogenous Leukemia After Allogeneic Bone Marrow Transplantation: A Taiwan Experience. Cancer Investigation. 20(7-8). 880–888. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact